Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009
- 15 December 2009
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 151 (12) , 829-839
- https://doi.org/10.7326/0000605-200912150-00157
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in HumansNew England Journal of Medicine, 2009
- Quantifying the Routes of Transmission for Pandemic InfluenzaBulletin of Mathematical Biology, 2008
- Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trialThe Lancet, 2007
- Strategies for mitigating an influenza pandemicNature, 2006
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) VaccineNew England Journal of Medicine, 2006
- The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of ageVaccine, 2006
- Is Exposure to Sick or Dead Poultry Associated With Flulike Illness?Archives of internal medicine (1960), 2006
- Recommendations of the Panel on Cost-Effectiveness in Health and MedicineJAMA, 1996
- Immunisation and herd immunityThe Lancet, 1990
- Influenza A: infection and reinfectionEpidemiology and Infection, 1984